Q4/2024 12/28/2024 EPS 2.660 ZacksConsensus 2.500 ActVsEst 0.160 - Beat

Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Wall Street Horizon

Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference CallBusiness Wire
- Contract Research Organization (CRO) Market Set to Grow at a CAGR of 8.1% Through 2034 as Biopharma Firms Seek Cost-Effective, Scalable R&D Solutions [Yahoo! Finance]Yahoo! Finance
- Astraveus Strengthens Leadership Team and Board [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $160.00 to $145.00. They now have an "equal weight" rating on the stock.MarketBeat
CRL
Earnings
- 2/19/25 - Beat
CRL
Sec Filings
- 4/17/25 - Form SCHEDULE
- 4/2/25 - Form ARS
- 4/2/25 - Form DEF
- CRL's page on the SEC website